BACKGROUND: The purpose of the present study was to determine whether longitudinal growth of the cortex occurs through intramembranous bone formation involving the periosteum or through endochondral bone formation involving the growth plate and to explore the cellular and biochemical mechanisms responsible for this process. METHODS: Cortical bone formation was studied in the metaphyses of growing New Zealand White rabbits by means of (1) oxytetracycline labeling and fluorescence microscopy, (2) computer-assisted histomorphometry, (3) osteoblast culture and [(3) H]-thymidine incorporation in the presence of periosteum or periosteum-conditioned medium, and (4) surgical insertion of membranes between the periosteum and the underlying spongiosa. RESULTS: Within the metaphyseal cortex, oxytetracycline labeling produced fluorescent closed curves outlining enlarging trabeculae derived from coalescing endochondral trabecular bone. In this region of coalescing trabeculae close to the periosteum, osteoblast surface was increased compared with trabeculae farther from the periosteum (p < 0.001). The osteoclast surface did not differ. In vitro, osteoblast proliferation was increased in the presence of periosteum (p < 0.001) or periosteum-conditioned medium (p < 0.001). Surgical insertion of permeable or impermeable membranes between the periosteum and the spongiosa did not prevent cortex formation. CONCLUSIONS: These observations demonstrate that metaphyseal cortical bone is formed by coalescence of endochondral trabecular bone. This coalescence is associated with increased osteoblast surface in the peripheral spongiosa. The increased osteoblast surface could be due to inductive effects of periosteum; in the present study, periosteum stimulated osteoblast proliferation in vitro but was not required for metaphyseal cortical bone formation in vivo. CLINICAL RELEVANCE: Understanding metaphyseal cortical growth may help to elucidate the pathophysiology of osseous growth disorders in children.
BACKGROUND: The purpose of the present study was to determine whether longitudinal growth of the cortex occurs through intramembranous bone formation involving the periosteum or through endochondral bone formation involving the growth plate and to explore the cellular and biochemical mechanisms responsible for this process. METHODS: Cortical bone formation was studied in the metaphyses of growing New Zealand White rabbits by means of (1) oxytetracycline labeling and fluorescence microscopy, (2) computer-assisted histomorphometry, (3) osteoblast culture and [(3) H]-thymidine incorporation in the presence of periosteum or periosteum-conditioned medium, and (4) surgical insertion of membranes between the periosteum and the underlying spongiosa. RESULTS: Within the metaphyseal cortex, oxytetracycline labeling produced fluorescent closed curves outlining enlarging trabeculae derived from coalescing endochondral trabecular bone. In this region of coalescing trabeculae close to the periosteum, osteoblast surface was increased compared with trabeculae farther from the periosteum (p < 0.001). The osteoclast surface did not differ. In vitro, osteoblast proliferation was increased in the presence of periosteum (p < 0.001) or periosteum-conditioned medium (p < 0.001). Surgical insertion of permeable or impermeable membranes between the periosteum and the spongiosa did not prevent cortex formation. CONCLUSIONS: These observations demonstrate that metaphyseal cortical bone is formed by coalescence of endochondral trabecular bone. This coalescence is associated with increased osteoblast surface in the peripheral spongiosa. The increased osteoblast surface could be due to inductive effects of periosteum; in the present study, periosteum stimulated osteoblast proliferation in vitro but was not required for metaphyseal cortical bone formation in vivo. CLINICAL RELEVANCE: Understanding metaphyseal cortical growth may help to elucidate the pathophysiology of osseous growth disorders in children.
Authors: Marilina Piemontese; Maria Almeida; Alexander G Robling; Ha-Neui Kim; Jinhu Xiong; Jeff D Thostenson; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien; Robert L Jilka Journal: JCI Insight Date: 2017-09-07
Authors: Sandra Hofmann; Monika Hilbe; Robert J Fajardo; Henri Hagenmüller; Katja Nuss; Margarete Arras; Ralph Müller; Brigitte von Rechenberg; David L Kaplan; Hans P Merkle; Lorenz Meinel Journal: Eur J Pharm Biopharm Date: 2013-09 Impact factor: 5.571
Authors: Allison R Altman; Wei-Ju Tseng; Chantal M J de Bakker; Abhishek Chandra; Shenghui Lan; Beom Kang Huh; Shiming Luo; Mary B Leonard; Ling Qin; X Sherry Liu Journal: Bone Date: 2015-08-06 Impact factor: 4.398
Authors: Alexander T Faje; Lamya Karim; Alex Taylor; Hang Lee; Karen K Miller; Nara Mendes; Erinne Meenaghan; Mark A Goldstein; Mary L Bouxsein; Madhusmita Misra; Anne Klibanski Journal: J Clin Endocrinol Metab Date: 2013-03-18 Impact factor: 5.958
Authors: Wook-Young Baek; Min-A Lee; Ji Won Jung; Shin-Yoon Kim; Haruhiko Akiyama; Benoit de Crombrugghe; Jung-Eun Kim Journal: J Bone Miner Res Date: 2009-06 Impact factor: 6.741
Authors: Serafim M Oliveira; Dindo Q Mijares; Gloria Turner; Isabel F Amaral; Mário A Barbosa; Cristina C Teixeira Journal: Tissue Eng Part A Date: 2009-03 Impact factor: 3.845